JBCHEPHARM.NS Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 май 2024 @ 13:00):

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally...

Stats
Объем за сегодня	25 785.00
Средний объем	197 054
Рыночная капитализация	287.62B
EPS	INR0 ( 2024-02-07 )
Дата следующего отчета о доходах	( INR0 ) 2024-05-21
Last Dividend	INR9.25 ( 2023-08-16 )
Next Dividend	INR0 ( N/A )
P/E	57.01
ATR14	INR3.02 (0.16%)

Объем Корреляция

Длинно: 0.11 (neutral)

Кратко: -0.18 (neutral)

Signal:(34.742) Neutral

J. B. Chemicals & Корреляция

10 Самые положительные корреляции
ASIANHOTNR.NS	0.803

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

J. B. Chemicals & Корреляция - Валюта/Сырье

0.13
( neutral )

-0.13
( neutral )

-0.20
( neutral )

0.03
( neutral )

0.36
( neutral )

0.02
( neutral )

J. B. Chemicals & Финансовые показатели

Annual	2022
Выручка:	INR31.49B
Валовая прибыль:	INR27.65B (87.80 %)
EPS:	INR26.50

FY	2022
Выручка:	INR31.49B
Валовая прибыль:	INR27.65B (87.80 %)
EPS:	INR26.50

FY	2022
Выручка:	INR24.24B
Валовая прибыль:	INR15.61B (64.39 %)
EPS:	INR49.86

FY	2021
Выручка:	INR20.06B
Валовая прибыль:	INR12.88B (64.23 %)
EPS:	INR57.96

Financial Reports:

No articles found.

J. B. Chemicals & Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR8.00 (N/A)	INR0 (N/A)	INR8.50 (N/A)	INR0 (N/A)	INR9.25 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

J. B. Chemicals & Dividend Information - Dividend Knight

Dividend Sustainability Score: 4.86 - low (61.49%) | Divividend Growth Potential Score: 5.35 - Stable (7.07%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.600	2003-06-30
Last Dividend	INR9.25	2023-08-16
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	32	--
Total Paid Out	INR149.65	--
Avg. Dividend % Per Year	1.66%	--
Score	3.51	--
Div. Sustainability Score	4.86
Div.Growth Potential Score	5.35
Div. Directional Score	5.11	--

Next Divdend (Est)
(2024-12-10)

INR9.67 Estimate 6.79 %

Dividend Stability

0.27 Very Poor

Dividend Score

3.51

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR2.00	0.62%
2019	INR5.00	3.21%
2020	INR12.00	5.59%
2021	INR16.50	3.19%
2022	INR16.50	1.89%
2023	INR17.75	1.80%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TRU.NS	Dividend Junior	2023-09-18	Annually	3	0.01%
PIXTRANS.NS	Dividend Junior	2023-07-11	Semi-Annually	3	0.43%
JKLAKSHMI.NS	Dividend Junior	2023-08-11	Annually	18	0.50%
DHRUV.NS	Dividend Junior	2023-09-05	Insufficient data to determine frequency	2	0.15%
SOBHA.NS	Dividend Junior	2023-07-28	Annually	18	0.43%
MMP.NS	Dividend Junior	2023-08-18	Annually	4	0.49%
HDFC.NS	Dividend Junior	2023-05-16	Annually	23	0.85%
BHAGCHEM.NS	Dividend Junior	2023-07-27	Annually	4	0.14%
RAIN.NS	Dividend Junior	2023-05-19	Annually	18	0.39%
KIRLOSBROS.NS	Dividend Junior	2023-07-25	Annually	17	0.99%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.152	1.500	6.96	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.198	1.500	8.91	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	59.22	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	14.16	2.00	5.28	10.00	[0 - 30]
freeCashFlowPerShareTTM	14.16	2.00	2.92	5.84	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.890	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.855	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.86

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	56.30	1.000	4.41	0	[1 - 100]
returnOnEquityTTM	0.198	2.50	9.30	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	14.16	2.00	5.28	5.84	[0 - 30]
dividendYielPercentageTTM	0.542	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	14.16	2.00	5.28	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	8.94	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0648	1.000	-0.879	0	[0.1 - 0.5]
Total Score				5.35

J. B. Chemicals &

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.